Literature DB >> 28233256

Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol.

Christian J Steib1, Alexander L Gerbes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28233256     DOI： 10.1007/s12072-017-9791-4

Source DB:  PubMed          Journal:  Hepatol Int        ISSN： 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  6 in total

1.  Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2015-06-03       Impact factor: 25.083

2.  Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure.

Authors:  Rajeshwar P Mookerjee; Marco Pavesi; Karen Louise Thomsen; Gautam Mehta; Jane Macnaughtan; Flemming Bendtsen; Minneke Coenraad; Jan Sperl; Pere Gines; Richard Moreau; Vicente Arroyo; Rajiv Jalan
Journal:  J Hepatol       Date:  2015-10-28       Impact factor: 25.083

3.  Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.

Authors:  R Bañares; E Moitinho; B Piqueras; M Casado; J C García-Pagán; A de Diego; J Bosch
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

4.  A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.

Authors:  Sang G Kim; Tae Y Kim; Joo H Sohn; Soon H Um; Yeon S Seo; Soon K Baik; Moon Y Kim; Jae Y Jang; Soung W Jeong; Bora Lee; Young S Kim; Ki T Suk; Dong J Kim
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

5.  Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.

Authors:  Vipin Gupta; Ramakant Rawat; Anoop Saraya
Journal:  Hepatol Int       Date:  2016-09-13       Impact factor: 6.047

6.  Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation.

Authors:  Joanna A Leithead; Neil Rajoriya; Nadeem Tehami; James Hodson; Bridget K Gunson; Dhiraj Tripathi; James W Ferguson
Journal:  Gut       Date:  2014-10-03       Impact factor: 23.059
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.